A subsequent report from this group corroborated these observations using a second antibody targeting Wnt5a (mAb5A16), which reduced endocytosis of Ror-2 and Frizzled-2 and decreased the metastatic activity of the GC cell line KKLS in vivo (Shojima et al., 2015). Here, WNT5A is linked to gastric cancer.